Publication | Closed Access

Enhancement of the anti-leukemic activity of cytokine induced killer cells with an anti-CD19 chimeric receptor delivering a 4-1BB-ζ activating signal

Autoimmune DiseaseAnti-leukemic ActivityImmunologyImmunologic MechanismAutoimmunityKiller CellsCellular Immune ResponseImmunotherapyMedicineCell BiologyAnti-cd19 Chimeric Receptor